Semaglutide and Testosterone: The Hormonal Changes with Weight Loss in Men

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

Semaglutide-induced weight loss in men, particularly reduction in visceral fat, significantly improves testosterone levels by decreasing aromatase activity and enhancing insulin sensitivity, addressing obesity-related hypogonadism.

# Semaglutide and Testosterone: Hormonal Changes with Weight Loss in Men

Semaglutide, a GLP-1 receptor agonist, has emerged as a highly effective treatment for weight loss and type 2 diabetes. Beyond its direct metabolic benefits, growing evidence indicates that semaglutide-induced weight loss can significantly impact hormonal profiles in men, particularly concerning testosterone levels. This is a crucial consideration given the strong link between obesity, insulin resistance, and hypogonadism (low testosterone) in men.

The Interplay of Obesity, Insulin Resistance, and Low Testosterone

Obesity is a well-established risk factor for secondary hypogonadism. Excess adipose tissue, particularly visceral fat, increases the activity of aromatase, an enzyme that converts testosterone into estrogen. This leads to lower circulating testosterone and higher estrogen levels. Furthermore, obesity often drives insulin resistance, which can directly impair testicular function and reduce testosterone production. The resulting low testosterone can, in turn, exacerbate obesity and insulin resistance, creating a vicious cycle.

Semaglutide"s Impact on Testosterone Through Weight Loss

Semaglutide"s primary mechanism of action involves enhancing glucose-dependent insulin secretion, suppressing glucagon, and slowing gastric emptying, all contributing to significant weight loss. This reduction in body fat, especially visceral fat, is the key driver behind the observed improvements in testosterone levels. As fat mass decreases, aromatase activity is reduced, leading to less testosterone conversion to estrogen. Concurrently, improved insulin sensitivity can directly enhance Leydig cell function in the testes, boosting endogenous testosterone production.

Clinical studies have demonstrated these effects. A 2024 study comparing semaglutide with testosterone replacement therapy (TRT) in men with obesity and low testosterone found that semaglutide was superior in improving body composition and comparably increased testosterone levels. Another clinical trial noted that men with low testosterone and type 2 diabetes who took semaglutide experienced an increase in total testosterone. Real-world data further supports these findings, showing that anti-obesity medications, including semaglutide, can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes.

Beyond Testosterone: Broader Hormonal and Metabolic Benefits

The hormonal benefits of semaglutide extend beyond testosterone. Weight loss achieved with semaglutide can also lead to improvements in other metabolic markers, such as reduced leptin resistance and improved glycemic control, which indirectly support a healthier hormonal milieu. While semaglutide does not directly modulate reproductive hormones, its profound effects on weight and insulin sensitivity create an environment conducive to hormonal balance.

Practical Implications for Men"s Health

For men struggling with obesity-related hypogonadism, semaglutide offers a promising therapeutic avenue. It addresses the root cause of low testosterone by promoting sustainable weight loss and improving metabolic health, rather than merely supplementing hormones. This approach can lead to more holistic and long-lasting improvements in sexual function, energy levels, mood, and overall quality of life. Clinicians should consider semaglutide as a viable option for men with obesity and low testosterone, particularly when weight loss is a primary goal.

Important Considerations

It is important to note that while semaglutide generally increases testosterone in men with obesity, individual responses can vary. The increase in testosterone is primarily an indirect effect of weight loss and metabolic improvement. Therefore, ongoing monitoring of hormonal levels and overall health is essential. Patients should discuss the potential benefits and risks with their healthcare provider to determine if semaglutide is an appropriate treatment option for their specific circumstances.